{"article": [{"url": "https://www.marketwatch.com/story/pfizer-to-help-manufacture-gileads-remdesivir-2020-08-07", "published": 1596788300.0, "headline": "Pfizer to help manufacture Gilead's remdesivir", "body": "Shares of Pfizer Inc. PFE, -0.27% gained 1.0% in premarket trading on Friday after it announced that it will help manufacture Gilead Sciences Inc.'s GILD, +0.82% COVID-19 treatment remdesivir as part of a multi-year agreement. Gilead's stock was up 0.6% on Friday before the market opened. This is a rare manufacturing deal between two of the world's largest drugmakers; \"Together, we are more powerful than alone,\" Pfizer CEO Albert Bourla said in a news release. Remdesivir, which has received an emergency authorization from the Food and Drug Administration as a treatment for severely ill COVID-19 patients, has not been formally approved by the regulator. Since the start of the year, Pfizer's stock is down 2.3%, shares of Gilead have gained 5.9%, and the S&P 500 SPX, +0.87% has rallied 3.6%."}]}